Sort
25,944 grants matching “neurodegeneration”
Electrophysiology of nuclear membrane InsP3 receptor
$400,000J. Kevin Kevin Foskett · University Of Pennsylvania · R37 · FY2014 · GM
Genetic and Molecular Definition of Histone Modifying Enzyme Functions
$400,000Sharon R Dent · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · GM
Genetic and Molecular Definition of Histone Modifying Enzyme Functions
$400,000Sharon R Dent · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · GM
Understanding Neurodegeneration Across the Scales
$400,000Ellen Kuhl · Stanford University · · FY2017 · ENG
Regulation of Glia-driven Neuroinflammation in Glaucoma
$400,000Gulgun Tezel · Columbia University Health Sciences · R01 · FY2020 · EY
Characterizing olfactory and associated reward-related cognitive functions in HIV
$400,000Thorsten Kahnt · National Institute On Drug Abuse · ZIA · FY2025 · DA
Genetic and Molecular Definition of Histone Modifying Enzyme Functions
$400,000Sharon R Dent · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · GM
Clinical, Neuroanatomic, and Pathologic Signatures of FTLD-tau in Dementia Phenotypes
$400,000Tamar D Gefen · Northwestern University At Chicago · R01 · FY2023 · AG
Role of Cytoskeletal Motor Proteins in Subcellular RNA Localization
$400,000Furqan Fazal · Baylor College Of Medicine · R35 · FY2025 · GM
Electrophysiology of nuclear membrane InsP3 receptor
$400,000J. Kevin Kevin Foskett · University Of Pennsylvania · R37 · FY2012 · GM
Clinical, Neuroanatomic, and Pathologic Signatures of FTLD-tau in Dementia Phenotypes
$400,000Tamar D Gefen · Northwestern University At Chicago · R01 · FY2022 · AG
Genetic and Molecular Definition of Histone Modifying Enzyme Functions
$400,000Sharon R Dent · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · GM
Phase 2 Study of Deferiprone in the Treatment of NBIA
$399,999Elliott P Vichinsky · Children'S Hospital & Res Ctr At Oakland · R01 · FY2014 · FD
Phase 2 Study of Deferiprone in the Treatment of NBIA
$399,999Elliott P Vichinsky · Children'S Hospital & Res Ctr At Oakland · R01 · FY2015 · FD
Neural exosome therapeutics for treating opioid-induced brain hypoxia injuries
$399,997Emily W Baker · Aruna Biomedical, Inc. · R43 · FY2025 · DA
Retinal Remodeling
$399,904Bryan William Jones · University Of Utah · R01 · FY2019 · EY
Retinal Remodeling
$399,904Bryan William Jones · University Of Utah · R01 · FY2020 · EY
COMPLEMENT MECHANISMS IN AMYLOID BETA PEPTIDE CLEARANCE
$399,820Joseph B Rogers · Banner Sun Health Research Institute · R01 · FY2006 · AG
Phase 2 Study of Deferiprone in the Treatment of NBIA
$399,815Elliott P Vichinsky · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · FD
Molecular Physiology of Mammalian InsP3 Receptors
$399,791J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2010 · MH
Regulation of the Autophagy Process in Organismal Aging
$399,750Malene Hansen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · AG
Roles of SN27 in regulating glutamate receptors during neurodegeneration
$399,750Huaxi Xu · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · AG
Mechanisms of Early Functional Loss in Diabetic Eye Disease
$399,750James Jason McAnany · University Of Illinois At Chicago · R01 · FY2023 · EY
Regulation of the Autophagy Process in Organismal Aging
$399,750Malene Hansen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · AG
Regulation of the Autophagy Process in Organismal Aging
$399,750Malene Hansen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG